Nalaganje...
Exposure–response for biomarkers of anticoagulant effects by the oral direct thrombin inhibitor AZD0837 in patients with atrial fibrillation
AIMS: AZD0837 is a novel oral anticoagulant investigated in clinical studies for stroke prevention in patients with atrial fibrillation (AF). It is bioconverted to its active form, AR‐H067637, a potent, specific and reversible thrombin inhibitor. The effects on coagulation biomarkers were correlated...
Shranjeno v:
| izdano v: | Br J Clin Pharmacol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4693476/ https://ncbi.nlm.nih.gov/pubmed/26174611 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12719 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|